Remote Jobs at Autolus Therapeutics

Autolus Therapeutics

501 - 1000 employees

Founded 2014

🧬 Biotechnology

💊 Pharmaceuticals

💰 $350M Post-IPO Equity - Autolus on 2024-02

Biotechnology • Pharmaceuticals

Autolus Therapeutics is a clinical-stage biotechnology company developing next-generation autologous CAR T cell therapies for cancer and autoimmune diseases. The company applies advanced cell programming, proprietary viral vectors, and semi-automated T cell manufacturing to engineer precision CAR T products, and is advancing a pipeline that includes programs for hematological malignancies, solid tumors, and autoimmune indications. Autolus emphasizes integrated development and commercialization efforts, clinical trials, and publication of its research.